Sort
39,280 grants matching “leukemia”
Histone Lysine deMethylation: Structures, Inhibitions and Mechanisms
$302,655Xiaodong Cheng · Emory University · R01 · FY2015 · GM
Translational Investigation of NF1 in Myeloid Luekemia
$302,544University Of California San Francisco · R01 · FY2003 · CA
Microfluidic patch clamp chips for multi-unit, high-throughput recordings
$302,484Albert Folch · University Of Washington · R01 · FY2010 · EB
Role of TEL and the t(12;21) in B cell ALL
$302,461Vanderbilt University · R01 · FY2002 · CA
HIV GAG PROTEINS FOR USE IN TARGETED DRUG DESIGN
$302,428Purdue University West Lafayette · R01 · FY2001 · AI
Molecular Characterization and Risk Stratification of Acute Myeloid Leukemia
$302,408Clara D Bloomfield · Ohio State University · P50 · FY2013 · CA
Molecular Mechanism of Leukemogenesis Involving AML1-ETO
$302,407Dong-Er Zhang · University Of California, San Diego · R01 · FY2008 · CA
Regulation of Gene Expression by PML
$302,378University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA
Role of TEL and the t(12;21) in B cell ALL
$302,378Vanderbilt University · R01 · FY2005 · CA
Role of TEL and the t(12;21) in B cell ALL
$302,378Vanderbilt University · R01 · FY2004 · CA
Role of TEL and the t(12;21) in B cell ALL
$302,378Vanderbilt University · R01 · FY2003 · CA
Regulation of Gene Expression by PML
$302,378University Of Texas Md Anderson Can Ctr · R01 · FY2004 · CA
Regulation of Gene Expression by PML
$302,378University Of Texas Md Anderson Can Ctr · R01 · FY2003 · CA
Role of MED12L- Associated Chromatin Enhancers in Pediatric Acute Megakaryoblastic Leukemia
$302,374Samrat Roy Choudhury · Arkansas Children'S Hospital Res Inst · P20 · FY2024 · GM
Role of MED12L- Associated Chromatin Enhancers in Pediatric Acute Megakaryoblastic Leukemia
$302,374Samrat Roy Choudhury · Arkansas Children'S Hospital Res Inst · P20 · FY2025 · GM
Role of MED12L- Associated Chromatin Enhancers in Pediatric Acute Megakaryoblastic Leukemia
$302,374Samrat Roy Choudhury · Arkansas Children'S Hospital Res Inst · P20 · FY2023 · GM
EM Cryst. Core
$302,343Mark Jay Yeager · University Of Utah · P50 · FY2012 · GM
Development of a vaccine against SARS-CoV
$302,290Case Western Reserve University · R21 · FY2004 · AI
TYROSINE KINASE ONCOGENES IN ACUTE MYELOID LEUKEMIAS
$302,258James D Griffin · Dana-Farber Cancer Inst · P01 · FY2008 · CA
Structure-Function of Protein Deacetylases
$302,257Ronen Marmorstein · Wistar Institute · R01 · FY2007 · CA
Mechanistic Studies of Type II Topoisomerases and Topoisomerase-Targeted Agents
$302,225Neil Osheroff · Vanderbilt University · R01 · FY2021 · GM
Mechanistic Studies of Type II Topoisomerases and Topoisomerase-Targeted Agents
$302,225Neil Osheroff · Vanderbilt University · R01 · FY2020 · GM
Mechanistic Studies of Type II Topoisomerases and Topoisomerase-Targeted Agents
$302,225Neil Osheroff · Vanderbilt University · R01 · FY2019 · GM
Mechanistic Studies of Type II Topoisomerases and Topoisomerase-Targeted Agents
$302,225Neil Osheroff · Vanderbilt University · R01 · FY2018 · GM
TRANSCRIPTIONAL ERYTHROID CELL DIFFERENTIATION
$302,206Children'S Hospital Of Philadelphia · R01 · FY2003 · DK